Issue 5, 2025

Platinum(ii) complexes of aryl guanidine-like derivatives as potential anticancer agents: between coordination and cyclometallation

Abstract

The preparation of a wide variety of Pt(II) complexes with aryl guanidines and their potential application as anticancer agents have been explored. A relatively facile synthesis of cyclometallated Pt(II) complexes of arylguanidines, preparation of Pt(II) guanidine coordination complexes and an in situ activation of platinum arylguanidine complexes with acetonitrile to create a bidentate aryl iminoguanidine Pt(II) complex were achieved. Cyclometallation methodology was extended to create a water-stable conjugate incorporating two Pt(II) ions and a diaryl bis-guanidine DNA minor groove binder. Several crystal structures were obtained confirming these complexation modes. The cyclometallated Pt(II) complexes were particularly stable to aqueous environments and were tested for Reactive Oxygen Species generation and anticancer activity in a leukaemia cancer cell line.

Graphical abstract: Platinum(ii) complexes of aryl guanidine-like derivatives as potential anticancer agents: between coordination and cyclometallation

Supplementary files

Article information

Article type
Paper
Submitted
13 Jan 2025
Accepted
20 Jan 2025
First published
04 Feb 2025
This article is Open Access
Creative Commons BY license

RSC Adv., 2025,15, 3427-3438

Platinum(II) complexes of aryl guanidine-like derivatives as potential anticancer agents: between coordination and cyclometallation

P. O'Sullivan, V. Previtali, B. Twamley, C. J. Marmion, A. R. McDonald and I. Rozas, RSC Adv., 2025, 15, 3427 DOI: 10.1039/D5RA00310E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements